InvestorsHub Logo
Followers 230
Posts 15196
Boards Moderated 0
Alias Born 03/30/2005

Re: To infinity and beyond! post# 320639

Wednesday, 08/26/2020 7:05:28 AM

Wednesday, August 26, 2020 7:05:28 AM

Post# of 403039
Its the ic50 value to show the lowest effective dosing.

From the pr
Brilacidin has now exhibited robust in vitro anti-SARS-CoV-2 efficacy at low concentrations, well below already established clinically-achievable concentrations based on pharmacokinetics observed in the Company’s Phase 2b clinical trial of Brilacidin in Acute Bacterial Skin and Skin Structure Infections.

the above is all IMHO (consider this my safe harbor statement)

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News